PHOENIX, June 17, 2025 /PRNewswire/ — Calviri, Inc, a company focused on ending cancer in dogs and people, announces the publication of High-sensitivity multicancer detection of stage 1 cancer in dogs in the American Journal of Veterinary Research of a novel diagnostic for the sensitive detection of five major dog cancers at stage 1 including canine lymphoma, hemangiosarcoma, osteosarcoma, mast cell tumors and soft tissue sarcomas. In addition, the paper describes the test’s accurate determination of tissue of origin for these cancers.
Category Archives: AZBio News
Caris Life Sciences Completes Initial Public Offering (IPO)
Reuters reports that Caris Life Sciences raised $494.1 million in its Nasdaq initial public offering
C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes
TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes (T1D). Continue reading
Life Sciences Workforce Collaborative (LSWC) Officially Launches to Strengthen Talent Pipelines Across the U.S.
Formerly the Coalition of State Bioscience Institutes (CSBI), LSWC to drive national coordination and visibility for life sciences workforce development
Wexford Science & Technology Launches Pre-Leasing for 800 PBC
Builds on Momentum of PBC, ASU Health With 850 PBC Nearing Full CapacityContinue reading
FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
The U.S. Food and Drug Administration today announced its Commissioner’s National Priority Voucher (CNPV) program to enhance the health interests of Americans. The new voucher may be redeemed by drug developers to participate in a novel priority program by the FDA that shortens its review time from approximately 10-12 months to 1-2 months following a sponsor’s final drug application submission.Continue reading
Global Impact of Phoenix Bioscience Core and TGen Featured in New BBC Content Series
BOSTON – The Translational Genomics Research Institute (TGen), part of City of Hope, took part in a new global content series presented by the Biotechnology Innovation Organization (BIO) and produced by BBC StoryWorks Commercial Productions. TGen is a leading biomedical research organization based in the Phoenix Bioscience Core (PBC).
Smart sensors and smarter health: How AI and wearables are reimagining preventive health care
University of Arizona Health Sciences researchers are harnessing artificial intelligence and wearable tech to forecast labor, detect stress and transform how we monitor our health – before symptoms appear.Continue reading
BioLab Holdings Founders Honored as Entrepreneurs of the Year
Robert Maguire & Jaime Leija, Cofounders of BioLab Holdings, Inc. in Mesa, Arizona were honored with the EY Entrepreneur Of The Year 2025 Pacific Southwest Award